Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Other Non-Current Liabilities (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Other Non-Current Liabilities came in at $59.6 million in Q2 2026, up 14.77% on a YoY basis from $51.9 million in Q2 2025, and down 0.87% quarter-over-quarter from $60.1 million in Q1 2026.

Analysis

Medpace Holdings (MEDP) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has reported Other Non-Current Liabilities for 12 consecutive years, with $59.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non-Current Liabilities rose 14.77% year-over-year to $59.6 million; the trailing twelve-month figure through Jun 2026 stood at $59.6 million (up 14.77% YoY), and the FY2025 full-year result was $57.7 million, up 34.92% from the prior year.
  • Other Non-Current Liabilities declined to $59.6 million in Q2 2026 per MEDP's latest filing, from $60.1 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $60.1 million in Q1 2026 and bottomed at $17.2 million in Q1 2022.
  • Historically, Other Non-Current Liabilities has averaged $35.6 million across 5 years, with a median of $29.2 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities rose 6.93% in 2022, then jumped 82.07% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $22.7 million in 2022, then climbed by 24.32% to $28.2 million in 2023, then soared by 51.43% to $42.7 million in 2024, then surged by 34.92% to $57.7 million in 2025, then grew by 3.35% to $59.6 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $59.6 million, $60.1 million, and $57.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.58 Mn
Mar 31, 2026 60.10 Mn
Dec 31, 2025 57.66 Mn
Sep 30, 2025 54.49 Mn
Jun 30, 2025 51.92 Mn
Mar 31, 2025 52.95 Mn
Dec 31, 2024 42.73 Mn
Sep 30, 2024 30.70 Mn
Jun 30, 2024 29.27 Mn
Mar 31, 2024 29.08 Mn
Dec 31, 2023 28.22 Mn
Sep 30, 2023 23.12 Mn
Jun 30, 2023 22.95 Mn
Mar 31, 2023 22.79 Mn
Dec 31, 2022 22.70 Mn
Sep 30, 2022 17.56 Mn
Jun 30, 2022 17.26 Mn
Mar 31, 2022 17.22 Mn
Dec 31, 2021 17.75 Mn
Sep 30, 2021 16.06 Mn